Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

  • receive the eCopy two days prior to the printed edition.
  • can partake in our online MCQs.
  • can enter our online sports quiz. is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.

Study raises concern about crowdfunding for cancer treatments

By Paul Mulholland - 17th Feb 2020 | 37 views

A study presented at the recent Irish Society of Medical Oncology (ISMO) Fellowship and Bursary Awards meeting in Dublin collected concerning evidence about patients raising money for cancer treatments, including immunotherapy for “unlicensed indications” and alternative therapy with “no evidence base”.

The study, which was titled ‘Crowdfunding for anticancer therapies: An analysis of non-US GoFundMe pages’, was conducted by Dr Shahid Iqbal and Dr Dearbhaile Collins, who are both based in Cork University Hospital.

They set out to analyse what the current non-US GoFundMe cancer pages were requesting monetary donations for in order to get a deeper understanding of this unregulated activity. For the research, 150 non-US GoFundMe web pages were reviewed between November 2019 to January 2020.

US web pages were excluded on account of the markedly different healthcare systems, with the majority requesting basic healthcare not covered by patient health insurance. Data collected included clinicopathological details such as age, gender, cancer type and stage of disease, in addition to the type of treatments being sought for funding, the total amount of funding sought and the quantity of donors.

The majority of the requestors had brain cancer, followed by breast cancer and ovarian cancer. The median amount of money requested was €48,205.

The highest amount requested by a patient was €588,759. Of the 150 pages, 89 were from the UK (59 per cent), 24 from Ireland (16 per cent), 12 from Australia (8 per cent) and 10 from Canada (7 per cent).

 “Our analysis has identified that these platforms are predominantly used for requesting financial support, but worryingly, a large proportion are requesting immunotherapy for unlicensed indications and alternative therapies with no evidence base to support its use,” according to the authors. “Future efforts to improve patient education are required to better manage this route of cancer funding.”

Leave a Reply

Latest Issue
medical news
The Medical Independent 19th May 2022

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read